Abstract
BACKGROUND
Spinal cord ependymomas are typically intramedullary and rarely present as intradural extramedullary (IDEM) tumors. Here, the authors report a case of a long-segment thoracic IDEM ependymoma that was surgically treated, along with a review of the existing literature on this uncommon presentation.
OBSERVATIONS
A 27-year-old female presented with a 1-year history of low back pain. The condition was initially mild and managed conservatively; however, 6 weeks prior to presentation, she developed progressive weakness in both lower limbs. Spinal MRI revealed a large IDEM mass along the ventral aspect of the thoracolumbar spine. The patient underwent laminoplasty (T9–L1 laminae) and gross-total tumor excision. The procedure was well tolerated, and no postoperative complications were observed. Histopathological examination confirmed the diagnosis of a WHO grade 2 ependymoma. At the 2-year follow-up, the patient had normal neurological function, and MRI revealed no evidence of recurrence.
LESSONS
IDEM exophytic growth of spinal ependymomas is rare but highly surgically treatable. Although the prognosis is favorable following complete excision, careful attention to the adjacent spinal anatomy is essential to minimize the complications. Further studies are needed to evaluate the role of adjuvant therapy.
Keywords: intradural, extramedullary, spinal ependymoma, myxopapillary ependymoma, ventral
ABBREVIATIONS: GTR = gross-total resection, IDEM = intradural extramedullary, MEP = motor evoked potential, SSEP = somatosensory evoked potential
Ependymoma is the most common intramedullary spinal tumor in adults. It arises from ependymal cells lining the central canal of the spinal cord and is therefore typically intramedullary, except for tumors located in the filum terminale or the conus medullaris.1–3 However, it can rarely present as an intradural extramedullary (IDEM) tumor, a phenomenon described only in a limited number of case reports.4 Because of the rarity of IDEM ependymomas, their clinical features and optimal management remain poorly understood. Here, we present a case of a long-segment thoracic spine IDEM ependymoma that was surgically treated, along with a review of the existing literature on this uncommon presentation.
Illustrative Case
We present the case of a 27-year-old female housewife and mother of one child with no significant past medical history, who presented with a 1-year history of back pain that began during pregnancy. The pain was initially mild and was managed conservatively with analgesics. However, 6 weeks before presentation to our hospital, she developed progressive weakness in both lower limbs without associated sphincter disturbance. On current presentation, she was alert and ambulated with assistance.
Neurological examination revealed unremarkable cognitive, cranial nerve, and upper extremity function. Motor examination of the lower extremities demonstrated symmetrical weakness of 4/5 in all muscle groups, more marked proximally, with normal symmetric tendon reflexes. The sensory examination was unremarkable. There were no skin stigmata or family history of neurofibromatosis.
MRI of the thoracolumbar spine (Fig. 1) demonstrated a large IDEM mass lesion along the ventral aspect of the spinal cord, extending from T8–9 to L1. The cranial part of the lesion was not clearly separable from the spinal cord, with an associated intramedullary high signal intensity, likely representing edema. The mass was hypointense to the spinal cord on T1-weighted images and hyperintense on T2-weighted images, with multiple intralesional signal voids representing small vessels. Extension to the bilateral neural foramina was observed at the T10–11, T11–12, and T12–L1 levels. In postcontrast images, the mass demonstrated heterogeneous enhancement. Brain and cervical spine MRI findings were unremarkable.
FIG. 1.
Preoperative MR images of the thoracic spine demonstrating a large IDEM mass along the ventral aspect of the spinal cord, causing significant mass effect from T8–9 to L1. The mass appeared isointense on a sagittal T1-weighted image (A) and hyperintense on T2-weighted sagittal (B) and axial (D) images. Postcontrast, it demonstrated heterogeneous enhancement on sagittal (C) and axial (E) images. There was extension to the bilateral neural foramina at T10–11, T11–12, and T12–L1 (E).
This constellation of findings suggests IDEM tumors, such as schwannoma and meningioma, and primary exophytic intramedullary spinal cord neoplasms, such as ependymoma, hemangioblastoma, and astrocytoma, as potential causes.
Surgical planning was performed with the patient positioned on a Jackson table and fluoroscopic localization of the T8–L1 level. Intraoperative monitoring was performed using motor evoked potentials (MEPs) and somatosensory evoked potentials (SSEPs). The patient underwent multilevel thoracolumbar laminoplasty (T9–L1) with rostrally hinged laminae. Midline durotomy was performed, and the spinal cord was found to be stretched from the ventral mass. Under the microscope, the denticulate ligaments were cut at multiple levels on both sides to allow spinal cord rotation and reflection during tumor resection. The tumor was identified ventral to the spinal cord, encasing, but not infiltrating, the nerve roots. However, at the upper end, there was a ventral attachment to the spinal cord. The tumor was rubbery in consistency and mildly vascularized. Using microsurgical dissection and ultrasonic aspiration, we resected the tumor through working windows created between the nerve roots at multiple spinal levels. Gross-total resection (GTR) was achieved while preserving the spinal nerve roots. There were no changes in SSEP or MEP signals throughout the surgery (Video 1).
VIDEO 1. Intraoperative video demonstrating the miscroscopic surgical technique for gross-total resection of a ventral IMED tumor in T8–9 to L1 region. Click here to view.
The patient tolerated the procedure well and did not experience any worsening of neurological deficits. An immediate postoperative MRI study confirmed complete tumor resection. Postoperatively, the patient had an uneventful recovery and was discharged in good clinical and neurological condition.
Histopathological examination revealed a neoplasm with oval and uniform cell nuclei with a fibrillary background, hypo- and hypercellular areas, perivascular pseudorosettes, and true ependymal rosettes. Focal areas of hemosiderin-laden macrophages and small areas of necrosis were present. Up to 2 mitotic figures per 10 high-power fields were identified. Immunohistochemical analysis revealed diffuse positivity for GFAP and S100, while EMA was negative. The Ki-67 index was up to 10% in hotspot areas. Overall, the findings were most consistent with those of a WHO grade 2 ependymoma (Fig. 2).
FIG. 2.
H&E stains at ×40 (A) and ×100 (B) original magnification, revealing a neoplasm with a fibrillary background, alternating hypocellular and hypercellular areas, perivascular pseudorosettes, and true ependymal rosettes. Immunohistochemical stains for GFAP (C) and S100 (D) showing diffuse positivity, while EMA was negative. Overall, the findings were consistent with those of a WHO grade 2 ependymoma.
The patient had a 2-year follow-up, clinically and radiologically, with resolution of her prior weakness, no evidence of tumor recurrence on her last MRI study, and no adjuvant therapy was advised (Fig. 3).
FIG. 3.
Follow-up MR images obtained at 2 years demonstrating no evidence of recurrent tumors. Sagittal T1-weighted MR image (A) demonstrating flattening of the spinal cord and sagittal (B) and axial (D) T2-weighted images showing stable intramedullary high T2 signal intensity. No abnormal contrast enhancement was observed in the surgical bed along the cord surface or nerve roots on sagittal (C) and axial (E) T1-weighted images postcontrast.
Informed Consent
The necessary informed consent was obtained in this study.
Discussion
Observations
Spinal ependymomas are typically intramedullary tumors that are often benign. Ependymomas are believed to originate from ependymal cells. In the spinal cord, these cells are predominantly located along the central canals. However, some ependymal cells are thought to persist during neural tube closure, potentially giving rise to IDEM ependymomas.1 Spinal IDEM ependymomas are uncommon entities within the broad spectrum of spinal cord tumors.2 These tumors typically arise from ependymal cells and grow through the anterior/anterolateral surface of the spinal cord as an exophytic tumor, expanding in the ventral aspect of the spinal canal adjacent to the dural sac (Fig. 4). They are often misdiagnosed because of their rarity and overlap in clinical features with more common extramedullary pathologies.
FIG. 4.

A: Illustration demonstrating attachment of the tumor to the spinal cord in the current case. B: Postoperative MR image showing the origin of the tumor and exophytic path location.
Our literature search in August 2025 identified 214 articles related to IDEM tumors. After screening for relevance, 90 articles unrelated to spinal ependymoma were excluded, leaving 124 articles for review. Of these, 50 articles describing intramedullary ependymomas were excluded, leaving 74 articles to be reviewed. A further 34 articles were excluded because they lacked specific tumor location details, leaving 40 eligible studies. Among these, 30 articles were excluded because they did not clearly describe the ventral (anterior) location of the tumor. Ultimately, 10 articles met the inclusion criteria, representing reported cases of ventral IDEM spinal ependymomas (Supplemental Fig. 1).5–14
The literature review summarized in Table 1 describes a synopsis of 10 cases of ventral IDEM spinal ependymomas that have been documented and confirmed through histological examination. Ependymomas are generally more common in women. In a review article, Duffau et al. hypothesized the existence of hormonal components.3 Among the cases presented in our review, including our case, 7 of the 11 patients were female.5–8,13 The mean age was 40 years (range 17–62 years). The thoracic region of the spinal cord is a common location for IDEM ependymomas, in contrast to intramedullary ependymomas, which are more commonly found in the cervical spinal cord. In this review, IDEM ependymomas were focal WHO grade 2 and located in the thoracic and cervical regions in 3 cases each (Table 1). Multifocal and disseminated tumors are usually WHO grade 3 and were reported in 4 cases involving the cervicomedullary junction, lumbar, sacral, and cauda equina regions, 2 of which had intracranial dissemination.7,11,13,14 Typical clinical symptoms include slowly progressive myelopathy with pain and motor deficits depending on the tumor location.
TABLE 1.
Review of the literature on ventral IDEM spinal ependymoma
| Authors & Year | Age (yrs) & Sex | Location | Surgical Management | Intraop Findings | Pathology | Adjuvant Therapy | Outcome |
|---|---|---|---|---|---|---|---|
| Wolfla et al., 19975 | 59, F | Focal, T10–11 | Laminectomy, GTR | Circumscribed, encapsulated, pinkish mass, not in continuity w/ the spinal cord, dura, or rootlets | Ependymoma, NOS | None | FU at 6 mos: recovery of neurological deficit; no recurrence |
| Payer et al., 19996 | 62, F | Focal, T6–7 | Hemilaminectomy & costotransversectomy, GTR | Tumor was yellowish-brown, encapsulated, & well demarcated from the spinal cord & nerve roots laterally & less so medially | Ependymoma, WHO grade 2 | None | FU NS: improving Brown-Séquard syndrome below T6 |
| Schuurmans et al., 20067 | 29, F | Multisegmental focal, C3–6 & L5–S1 | Laminectomy, GTR | Tumor appeared to be connected to the cord only at C5 | Ependymoma, WHO grade 3 | Spinal radiation | FU at 6 mos; improved weakness but w/ residual painful sensations in legs & slight micturition difficulties due to postradiation myelopathy; no spinal recurrent tumor; FU at 2 yrs: developed intracranial recurrence |
| Fasoli et al., 20088 | 32, F | Focal, T3–5 | Laminectomy, GTR | Well circumscribed, not infiltrating the spinal cord | Ependymoma, NOS | None | FU at 2 yrs: no neurological deficit; no recurrence |
| Kinsman et al., 20119 | 53, M | Focal, C5–7 | Laminectomy, GTR | Tumor was grossly purplish-brown, exophytic & very closely adherent to the lateral wall of the spinal cord | Ependymoma, WHO grade 3 | Spinal radiation | FU NS: recovery of neurological deficit |
| Ha & Shin, 201210 | 36, F | Focal, C6–T1 | Laminectomy, GTR | Stalk attached the tumor to the C7 spinal nerve root | Ependymoma, WHO grade 2 | None | FU at 6 mos: no neurological deficit; no recurrence |
| Guarnieri et al., 201411 | 53, M | Multisegmental focal, cervical & thoracic spine | Laminectomy, STR | Tumor was soft, w/ no attachment to the dura or spinal cord; arachnoid infiltration was noted | Ependymoma, WHO grade 2 | Chemotherapy (carboplatin) | FU NS: recovery of neurological deficit |
| Pomeraniec et al., 201512 | 23, M | Focal, C4–7 | Laminoplasty, STR | Tumor was adherent to & partially enveloped the nerve roots, including those at the exiting C6 level | Ependymoma, WHO grade 3 | Craniospinal radiation | FU at 1 yr: recovery of neurological deficit; stable residual nodular lesions along the surface of the cervical & thoracic spinal cord |
| Chakravorty et al., 201713 | 47, F | Multisegmental focal, S2 & T9; diffuse lesions at the cervicomedullary junction to the lumbar region | Laminectomy, GTR | Soft gray-pink tumor arising from nerve roots | Ependymoma, WHO grade 3 | Craniospinal radiation | FU at 4 yrs: recovery of neurological deficit; stable spinal residual lesions |
| Garg et al., 201914 | 17, M | Multisegmental diffuse, T6–S2 | Laminectomy & aspiration/biopsy | Cystic mass | Ependymoma, WHO grade 2 | Radiation & chemo | FU at 12 mos: recovery of neurological deficit; extensive spinal leptomeningeal recurrence & cranial metastasis; craniotomy & biopsy revealed ependymoma, WHO grade 3 |
| Present case | 27, F | Multisegemental focal, T9–L1 | Laminoplasty, GTR | Tumor exhibited a soft, rubbery consistency, was adherent to the dura, & appeared exophytic w/ adherence to the rt anterior aspect of the spinal cord, w/o involvement of the nerve roots | None | FU at 2 yrs: full recovery of preop neurological deficits; no recurrence |
FU = follow-up; NOS = not otherwise specified; NS = not specified; STR = subtotal resection.
On preoperative imaging, differentiating IDEM ependymomas from other IDEM tumors, such as meningiomas or schwannomas, can be challenging. These tumors may appear encapsulated without clear neural or dural attachment or present as dumbbell-shaped lesions extending into the paravertebral region.2 This was demonstrated in our case, in which the mass extended into the bilateral neural foramina at multiple locations.
To our knowledge, our case represents another example of a large multisegmental ventral IDEM ependymoma with bilateral neural foraminal extension mimicking a peripheral nerve sheath tumor.10 Although IDEM ependymomas have been previously described, most reported lesions are focal, spanning one to two spinal segments, and lack foraminal involvement.
This radiographic appearance significantly challenged the preoperative differential diagnosis and surgical planning, highlighting the importance of considering IDEM ependymoma in the differential diagnosis of ventral IDEM lesions with foraminal extension, particularly when imaging characteristics are atypical for more common pathologies such as schwannoma or meningioma.
GTR remains the primary treatment for IDEM ependymomas. Owing to their well-encapsulated nature, these tumors are often amenable to complete resection, which offers the best prognosis for patients with these tumors. However, the ventral location poses significant technical challenges because access requires careful spinal cord mobilization while preserving ventral neurovascular structures and functional nerve roots.
In our literature review, most patients with ventral IDEM ependymomas underwent laminectomy or laminoplasty.5,7–14 In contrast, hemilaminectomy may be considered in cases in which the tumor is located laterally in the spinal canal.6 Most reported IDEM ependymomas were WHO grade 2, which require GTR and follow-up.5,6,8,10,11,13 In some cases, they were WHO grade 3 and required adjunctive radiotherapy and/or chemotherapy.5–10,13 Most patients showed near-complete recovery of neurological deficits.
The present case expands the limited literature on ventral IDEM spinal ependymomas and emphasizes several important clinical considerations for their management. First, these lesions may demonstrate extensive foraminal extension and radiographically mimic more common IDEM tumors, such as schwannomas. Second, despite their benign histological appearance, their ventral location can significantly complicate surgical exposure and safe resection because of their location anterior to the spinal cord and their proximity to neurovascular structures. Finally, awareness of this rare entity may improve preoperative diagnostic accuracy and facilitate surgical planning aimed at maximizing safe GTR while minimizing neurological morbidity.
Lessons
Primary ventral IDEM ependymomas are exceptionally rare lesions that may mimic nerve sheath tumors or meningiomas on preoperative imaging, particularly when associated with extensive foraminal extension. GTR remains the cornerstone of treatment; however, ventral tumor location presents unique microsurgical challenges that require meticulous spinal cord manipulation and preservation of adjacent neurovascular structures to ensure optimal outcomes. This case broadens the spectrum of radiographic presentations reported for IDEM ependymomas and reinforces the importance of considering this diagnosis in atypical ventral IDEM lesions.
Disclosures
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Author Contributions
Conception and design: Baeesa, Alsindi, Basurrah. Acquisition of data: Baeesa, Alsindi. Analysis and interpretation of data: Baeesa, Alsindi. Drafting the article: Baeesa, Alsindi, Albakri, Basurrah. Critically revising the article: Baeesa, Alsindi, Albakri, Basurrah. Reviewed submitted version of manuscript: Baeesa, Alsindi, Albakri, Basurrah. Approved the final version of the manuscript on behalf of all authors: Baeesa. Administrative/technical/material support: Baeesa, Alsindi, Almansouri. Study supervision: Baeesa, Alsindi, Albakri.
Supplemental Information
Videos
Video 1. https://vimeo.com/1205498610.
Online-Only Content
Supplementary Materials
Supplemental Fig. 1. https://thejns.org/doi/suppl/10.3171/CASE26500.
Current Affiliations
Dr. Albakri: Makkah Health Cluster, Makkah, Saudi Arabia.
Correspondence
Saleh S. Baeesa: King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. sbaeesa@kfshrc.edu.sa; salehbaeesa@gmail.com.
References
- 1.Louis DN, Perry A, Wesseling P.The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251. doi: 10.1093/neuonc/noab106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Makino Y Kawanabe Y Fujimoto M Sato T Hoshimaru M.. A case of spinal ependymoma developed in the extramedullary location: a case report and literature review. NMC Case Rep J. 2021;8(1):601-608. doi: 10.2176/nmccrj.cr.2020-0354 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Duffau H Gazzaz M Kujas M Fohanno D.. Primary intradural extramedullary ependymoma: case report and review of the literature. Spine (Phila Pa 1976). 2000;25(15):1993-1995. doi: 10.1097/00007632-200008010-00021 [DOI] [PubMed] [Google Scholar]
- 4.Shields LBE, Sun DA, Highfield HA.Multifocal intradural extramedullary ependymoma, MYCN amplified: illustrative case. J Neurosurg Case Lessons. 2022;3(22):CASE22141. doi: 10.3171/CASE22141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wolfla CE Azzarelli B Shah MV.. Primary extramedullary ependymoma of the thoracic spine. Case illustration. J Neurosurg. 1997;87(4):643. doi: 10.3171/jns.1997.87.4.0643 [DOI] [PubMed] [Google Scholar]
- 6.Payer M Yonekawa Y Imhof HG.. Solitary thoracic intradural extramedullary ependymoma. J Clin Neurosci. 1999;6(4):344-345. doi: 10.1054/jocn.1997.0076 [DOI] [PubMed] [Google Scholar]
- 7.Schuurmans M Vanneste JAL Verstegen MJT van Furth WR. . Spinal extramedullary anaplastic ependymoma with spinal and intracranial metastases. J Neurooncol. 2006;79(1):57-59. doi: 10.1007/s11060-005-9114-9 [DOI] [PubMed] [Google Scholar]
- 8.Fasoli F, Minniti G, Serio N.Primary intradural extramedullary ependymoma: imaging findings and review of the literature. A case report. Neuroradiol J. 2008;21(2):239-243. doi: 10.1177/197140090802100214 [DOI] [PubMed] [Google Scholar]
- 9.Kinsman MJ Callahan JD Hattab EM Cohen-Gadol AA. . Extramedullary spinal ependymoma: a diagnostic challenge and review of the literature. Clin Neurol Neurosurg. 2011;113(8):661-664. doi: 10.1016/j.clineuro.2011.02.021 [DOI] [PubMed] [Google Scholar]
- 10.Ha SM Shin DA.. Intradural extramedullary ependymoma with spinal root attachment: a case report. Korean J Spine. 2012;9(3):250-252. doi: 10.14245/kjs.2012.9.3.250 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Guarnieri G Tecame M Izzo R Zeccolini F Genovese L Muto M.. Multisegmental diffuse intradural extramedullary ependymoma: an extremely rare case. Neuroradiol J. 2014;27(2):179-185. doi: 10.15274/NRJ-2014-10018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pomeraniec IJ Dallapiazza RF Sumner HM Lopes MB Shaffrey CI Smith JS.. Anaplastic extramedullary cervical ependymoma with leptomeningeal metastasis. J Clin Neurosci. 2015;22(12):1871-1876. doi: 10.1016/j.jocn.2015.06.015 [DOI] [PubMed] [Google Scholar]
- 13.Chakravorty A Frydenberg E Shein TT Ly J Earls P Steel T. . Multifocal intradural extramedullary anaplastic ependymoma of the spine. J Spine Surg. 2017;3(4):727-731. doi: 10.21037/jss.2017.11.10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Garg K Sharma R Dash C Agrawal D Sharma BS.. Spinal intradural extramedullary ependymoma with intracranial metastasis and leptomeningeal spread: a case report and comprehensive review of literature. Neurol India. 2019;67(5):1352-1357. doi: 10.4103/0028-3886.271269 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



